US Pharma MarketingSTAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing
The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing. global health research legal Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Pharmalot Pharma’s reputation among patient groups rose last year, but concerns…
The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing.
Source: STAT News Pharma